Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A11307 | 30945694 | J Genet | Genetics of nonalcoholic fatty liver disease in Asian populations. | 2019 | Details |
| A11310 | 30945129 | Curr Obes Rep | Nonalcoholic Fatty Liver Disease and Obesity Treatment. | 2019 | Details |
| A11315 | 30942551 | Obesity (Silver Spring) | Comparison of Abdominal Obesity and Fatty Liver and Their Association with Insulin Resistance and Metabolic Syndrome in Chinese Adults. | 2019 | Details |
| A11318 | 30940491 | Nutr Metab Cardiovasc Dis | Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese. | 2019 | Details |
| A11320 | 30939889 | Rev Esp Enferm Dig | Psoriasis and fatty liver: a harmful synergy. | 2019 | Details |
| A11326 | 30936733 | Diabetes Metab Syndr Obes | Ethnic differences and heterogeneity in genetic and metabolic makeup contributing to nonalcoholic fatty liver disease. | 2019 | Details |
| A11327 | 30936549 | Nat Med | Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer. | 2019 | Details |
| A11329 | 30935932 | Gastrointest Endosc | Duodenal mucosal resurfacing: proof-of-concept, procedural development, and initial implementation in the clinical setting. | 2019 | Details |
| A11335 | 30932742 | OMICS | Novel Serum Biomarkers for Noninvasive Diagnosis and Screening of Nonalcoholic Fatty Liver Disease-Related Hepatic Fibrosis. | 2019 | Details |
| A11346 | 30928918 | BMJ Open | Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: a systematic review and meta-analysis of randomised controlled trials. | 2019 | Details |
| A11347 | 30928418 | Dig Liver Dis | Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A11363 | 30921653 | Adv Med Sci | Can hepatokines be regarded as novel non-invasive serum biomarkers of intrahepatic lipid content in obese children? | 2019 | Details |
| A11366 | 30920583 | Endocr Rev | The Liver-α-Cell Axis and Type 2 Diabetes. | 2019 | Details |
| A11368 | 30920415 | Am J Gastroenterol | Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation. | 2019 | Details |
| A11374 | 30919335 | Adv Exp Med Biol | miRNA Regulation of Glucose and Lipid Metabolism in Relation to Diabetes and Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A11377 | 30918952 | Inflamm Bowel Dis | Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease. | 2019 | Details |
| A11378 | 30918873 | J Diabetes Metab Disord | Life-style-induced metabolic derangement and epigenetic changes promote diabetes and oxidative stress leading to NASH and atherosclerosis severity. | 2018 | Details |
| A11380 | 30918325 | Lab Invest | Human relaxin-2 attenuates hepatic steatosis and fibrosis in mice with non-alcoholic fatty liver disease. | 2019 | Details |
| A11384 | 30917546 | Nutrients | Non-Alcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: Role of Circulating Branched-Chain Amino Acids. | 2019 | Details |
| A11393 | 30915402 | Clin Exp Hepatol | Update on pathogenesis, diagnostics and therapy of nonalcoholic fatty liver disease in children. | 2019 | Details |
| A11394 | 30915401 | Clin Exp Hepatol | Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease. | 2019 | Details |
| A11396 | 30914267 | J Hepatol | Macrophage p38α promotes nutritional steatohepatitis through M1 polarization. | 2019 | Details |
| A11398 | 30912854 | Hepatology | Relationship Between PNPLA3 rs738409 Polymorphism and Decreased Kidney Function in Children With NAFLD. | 2019 | Details |
| A11399 | 30912337 | Endocrinol Metab (Seoul) | Implications of Mitochondrial Unfolded Protein Response and Mitokines: A Perspective on Fatty Liver Diseases. | 2019 | Details |
| A11403 | 30909521 | Cells | A New Targeted Lipidomics Approach Reveals Lipid Droplets in Liver, Muscle and Heart as a Repository for Diacylglycerol and Ceramide Species in Non-Alcoholic Fatty Liver. | 2019 | Details |
| A11413 | 30905315 | Adipocyte | Adipocytes as lipid sensors of oleic acid transport through a functional Caco-2/HT29-MTX intestinal barrier. | 2019 | Details |
| A11414 | 30905208 | Expert Rev Gastroenterol Hepatol | Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in HIV infection: a metabolic approach of an infectious disease. | 2019 | Details |
| A11423 | 30901029 | Endocr Rev | Emerging Roles for Serotonin in Regulating Metabolism: New Implications for an Ancient Molecule. | 2019 | Details |
| A11428 | 30898698 | Gene | Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5p. | 2019 | Details |
| A11430 | 30897538 | Biomed Pharmacother | Biological mechanisms and related natural modulators of liver X receptor in nonalcoholic fatty liver disease. | 2019 | Details |
| A11432 | 30896961 | Rev Esp Enferm Dig | Association between thymosin beta4 and non-alcoholic fatty liver disease. | 2019 | Details |
| A11434 | 30896957 | Rev Esp Enferm Dig | Bariatric and metabolic endoscopy in the handling of fatty liver disease. A new emerging approach? | 2019 | Details |
| A11436 | 30896868 | Mol Med Rep | Hepatic miR‑215 target Rictor and modulation of hepatic insulin signalling in rats. | 2019 | Details |
| A11439 | 30895694 | Phytother Res | The clinical effects of purslane (Portulaca oleracea) seeds on metabolic profiles in patients with nonalcoholic fatty liver disease: A randomized controlled clinical trial. | 2019 | Details |
| A11441 | 30893108 | Curr Opin Lipidol | Bile acid alterations in nonalcoholic fatty liver disease, obesity, insulin resistance and type 2 diabetes: what do the human studies tell? | 2019 | Details |
| A11442 | 30893090 | Curr Opin Clin Nutr Metab Care | Sarcopenic obesity in fatty liver. | 2019 | Details |
| A11443 | 30892882 | J Agric Food Chem | Preventive Efficiency of Green Tea and Its Components on Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A11446 | 30891617 | J Mol Med (Berl) | Innate immune regulatory networks in hepatic lipid metabolism. | 2019 | Details |
| A11451 | 30889343 | Rev Med Inst Mex Seguro Soc | Nonalcoholic hepatic steatosis: a silent disease | 2019 | Details |
| A11457 | 30888440 | Intensive Care Med | Obesity in the critically ill: a narrative review. | 2019 | Details |
| A11463 | 30885145 | BMC Gastroenterol | The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose. | 2019 | Details |
| A11467 | 30883738 | J Physiol | Challenging metabolic tissues with fructose: tissue-specific and sex-specific responses. | 2019 | Details |
| A11473 | 30881473 | Evid Based Complement Alternat Med | Jwa Kum Whan Attenuates Nonalcoholic Fatty Liver Disease by Modulating Glucose Metabolism and the Insulin Signaling Pathway. | 2019 | Details |
| A11474 | 30881345 | Front Endocrinol (Lausanne) | Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease. | 2019 | Details |
| A11477 | 30879920 | EBioMedicine | Arid1a regulates insulin sensitivity and lipid metabolism. | 2019 | Details |
| A11478 | 30879098 | Eur J Nutr | Moderate consumption of fermented alcoholic beverages diminishes diet-induced non-alcoholic fatty liver disease through mechanisms involving hepatic adiponectin signaling in mice. | 2019 | Details |
| A11480 | 30878016 | J Endocrinol | Short-term strength training reduces gluconeogenesis and NAFLD in obese mice. | 2019 | Details |
| A11481 | 30877708 | Diabetes Metab J | Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus. | 2019 | Details |
| A11492 | 30872135 | Arab J Gastroenterol | Relationship between lifestyle factors and nutritional status and non-alcoholic fatty liver disease among a group of adult Jordanians. | 2019 | Details |
| A11494 | 30871514 | BMC Complement Altern Med | Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial. | 2019 | Details |
| A11499 | 30870804 | Nutrition | Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver disease. | 2018 | Details |
| A11500 | 30870486 | PLoS One | Fecal and blood microbiota profiles and presence of nonalcoholic fatty liver disease in obese versus lean subjects. | 2019 | Details |
| A11505 | 30868315 | Acta Diabetol | Oral glucose effectiveness and metabolic risk in obese children and adolescents. | 2019 | Details |
| A11506 | 30867987 | PeerJ | Comparison of laboratory indices of non-alcoholic fatty liver disease for the detection of incipient kidney dysfunction. | 2019 | Details |
| A11522 | 30860877 | Am J Physiol Endocrinol Metab | Human Paneth cell α-defensin-5 treatment reverses dyslipidemia and improves glucoregulatory capacity in diet-induced obese mice. | 2019 | Details |
| A11526 | 30857678 | Food Chem | Quinoa intake reduces plasma and liver cholesterol, lessens obesity-associated inflammation, and helps to prevent hepatic steatosis in obese db/db mouse. | 2019 | Details |
| A11528 | 30856468 | J Nutr Biochem | Tissue-dependent effects of cis-9,trans-11- and trans-10,cis-12-CLA isomers on glucose and lipid metabolism in adult male mice. | 2019 | Details |
| A11542 | 30850637 | Sci Rep | Connectivity mapping of angiotensin-PPAR interactions involved in the amelioration of non-alcoholic steatohepatitis by Telmisartan. | 2019 | Details |
| A11543 | 30850619 | Sci Rep | Voluntary exercise in mice fed an obesogenic diet alters the hepatic immune phenotype and improves metabolic parameters - an animal model of life style intervention in NAFLD. | 2019 | Details |
| A11544 | 30850262 | Trends Endocrinol Metab | Calcium Signaling As a Therapeutic Target for Liver Steatosis. | 2019 | Details |
| A11548 | 30848932 | FASEB J | Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3. | 2019 | Details |
| A11549 | 30848827 | J Clin Endocrinol Metab | Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes. | 2019 | Details |
| A11550 | 30847862 | J Endocrinol Invest | Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes. | 2019 | Details |
| A11557 | 30841472 | Biomed Pharmacother | Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue. | 2019 | Details |
| A11558 | 30841442 | Biomed Pharmacother | Genistein can ameliorate hepatic inflammatory reaction in nonalcoholic steatohepatitis rats. | 2019 | Details |
| A11563 | 30838350 | Acta Myol | Prevalence of metabolic syndrome and non-alcoholic fatty liver disease in a cohort of italian patients with spinal-bulbar muscular atrophy. | 2018 | Details |
| A11564 | 30837878 | Front Pharmacol | G Protein-Coupled Receptor Kinase 2 (GRK2) as a Potential Therapeutic Target in Cardiovascular and Metabolic Diseases. | 2019 | Details |
| A11567 | 30836637 | Nutrients | Similar Weight Loss Induces Greater Improvements in Insulin Sensitivity and Liver Function among Individuals with NAFLD Compared to Individuals without NAFLD. | 2019 | Details |
| A11574 | 30833801 | World J Gastroenterol | Procyanidin B2 protects against diet-induced obesity and non-alcoholic fatty liver disease via the modulation of the gut microbiota in rabbits. | 2019 | Details |
| A11575 | 30833214 | Clin Nutr | Non-alcoholic fatty liver in hereditary fructose intolerance. | 2019 | Details |
| A11576 | 30833154 | Endocrinol Diabetes Nutr (Engl Ed) | Inflammatory stress and altered angiogenesis evoked by very high-fat diets in mouse liver. | 2019 | Details |
| A11577 | 30832745 | Br J Nutr | Dietary determinants of hepatic fat content and insulin resistance in overweight/obese children: a cross-sectional analysis of the Prevention of Diabetes in Kids (PREDIKID) study. | 2019 | Details |
| A11578 | 30832722 | Trials | Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: study protocol for a randomized clinical trial. | 2019 | Details |
| A11581 | 30831319 | Cell Mol Gastroenterol Hepatol | Defective Phosphatidylglycerol Remodeling Causes Hepatopathy, Linking Mitochondrial Dysfunction to Hepatosteatosis. | 2019 | Details |
| A11587 | 30828530 | Adv Sci (Weinh) | Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases. | 2018 | Details |
| A11589 | 30827909 | Endocrinol Diabetes Nutr (Engl Ed) | Document on a comprehensive approach to type 2 diabetes mellitus. | 2019 | Details |
| A11592 | 30826497 | Life Sci | Interrelation of liver vascularity to non-alcoholic fatty liver through a comparative study of the vasodilator effect of carvedilol or nicorandil in rats. | 2019 | Details |
| A11594 | 30825254 | Liver Int | MACK-3 (combination of hoMa, Ast and CK18): A promising novel biomarker for fibrotic non-alcoholic steatohepatitis. | 2019 | Details |
| A11604 | 30823334 | Environ Pollut | Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines. | 2019 | Details |
| A11609 | 30820969 | Hepatology | Dual Specificity Phosphatase 12 Regulates Hepatic Lipid Metabolism Through Inhibition of the Lipogenesis and Apoptosis Signal-Regulating Kinase 1 Pathways. | 2019 | Details |
| A11611 | 30820265 | World J Hepatol | Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects. | 2019 | Details |
| A11613 | 30819364 | J Am Coll Cardiol | Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art Review. | 2019 | Details |
| A11617 | 30818824 | Nutrients | A Pathophysiological Model of Non-Alcoholic Fatty Liver Disease Using Precision-Cut Liver Slices. | 2019 | Details |
| A11618 | 30818779 | Nutrients | Green Coffee Extract Improves Cardiometabolic Parameters and Modulates Gut Microbiota in High-Fat-Diet-Fed ApoE-/- Mice. | 2019 | Details |
| A11623 | 30814508 | Nat Commun | Hepatic Sdf2l1 controls feeding-induced ER stress and regulates metabolism. | 2019 | Details |
| A11631 | 30811073 | Hepatol Res | Hepatic gene expression in mouse models of non-alcoholic fatty liver disease after acute exercise. | 2019 | Details |
| A11635 | 30810254 | Int J Clin Pract | Impact of dapagliflozin, an SGLT2 inhibitor, on serum levels of soluble dipeptidyl peptidase-4 in patients with type 2 diabetes and non-alcoholic fatty liver disease. | 2019 | Details |
| A11640 | 30809151 | Front Physiol | LSEC Fenestrae Are Preserved Despite Pro-inflammatory Phenotype of Liver Sinusoidal Endothelial Cells in Mice on High Fat Diet. | 2019 | Details |
| A11662 | 30798914 | Med Hypotheses | Fructose-associated hepatotoxicity indexed by the lactate dehydrogenase isoenzyme LDH-5. | 2019 | Details |
| A11663 | 30798598 | J Agric Food Chem | Intestinal Barrier Function-Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota. | 2019 | Details |
| A11670 | 30796508 | Eur J Nutr | Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial. | 2019 | Details |
| A11697 | 30788048 | World J Diabetes | SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review. | 2019 | Details |
| A11698 | 30787925 | Front Immunol | The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity. | 2019 | Details |
| A11700 | 30787473 | Eur J Clin Nutr | The role of dietary sugars in health: molecular composition or just calories? | 2019 | Details |
| A11721 | 30777418 | Rev Med Inst Mex Seguro Soc | Molecular alterations induced by fructose and its impact on metabolic diseases | 2019 | Details |
| A11723 | 30776292 | J Clin Endocrinol Metab | Comorbidities in primary versus secondary school children with obesity and responsiveness to lifestyle intervention. | 2019 | Details |
| A11728 | 30774403 | Diabetes Metab Syndr Obes | The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010-2011. | 2019 | Details |
| A11731 | 30773673 | Clin Exp Pharmacol Physiol | Resveratrol protects against hepatic insulin resistance in a rat's model of non-alcoholic fatty liver disease by down-regulation of GPAT-1 and DGAT2 expression and inhibition of PKC membranous translocation. | 2019 | Details |
| A11739 | 30770098 | Biochem Biophys Res Commun | Genetic deletion of β2 adrenergic receptors exacerbates hepatocellular lipid accumulation in high-fat diet mice. | 2019 | Details |
| A11741 | 30770030 | Diab Vasc Dis Res | Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift. | 2019 | Details |